QCast: Data-Driven Dialogue in Drug Development
Episode 60: Oncology Phase 1 Trial Design
· 11 min · Episódio 60
Notas do episódio
In this QCast episode, Jullia and Tom discuss how oncology Phase 1 trial design has moved beyond simply identifying the maximum tolerated dose. They look at dose optimisation, escalation methods, simulation, data readiness, expansion cohorts, biomarkers and site capability, with a focus on how these elements affect real dose decisions. Key Takeaways Safety, exposure, pharmacodynamic information, early activity and longer-term tolerability can all influence the dose and regimen taken forward.S...
Site: quanticate.com
